Morningside Venture Investments Ltd, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 441,428 shares at $33.68 ($14.9M) on 2023-03-15, disclosed to the SEC on 2023-03-16.
Open-market sale of $14.9M AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.54 | 70,714 | $2.4M | 16.4% |
| 2 | $34.54 | 70,714 | $2.4M | 16.4% |
| 3 | $33.12 | 108,934 | $3.6M | 24.3% |
| 4 | $33.12 | 108,934 | $3.6M | 24.3% |
| 5 | $33.68 | 41,066 | $1.4M | 9.3% |
| 6 | $33.68 | 41,066 |
| $1.4M |
| 9.3% |
| Total | $33.68 avg | 441,428 | $14.9M | 100% |
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |